Medical Care
Global Sepsis Diagnostics Testing Market Research Report 2025
- Mar 11, 25
- ID: 77369
- Pages: 81
- Figures: 87
- Views: 20
The global market for Sepsis Diagnostics Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sepsis Diagnostics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Diagnostics Testing.
The Sepsis Diagnostics Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sepsis Diagnostics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Diagnostics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Axis Shield
Becton Dickinson
bioMérieux
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific
Segment by Type
Point-of-Care Testing
Laboratory Testing
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Diagnostics Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sepsis Diagnostics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Diagnostics Testing.
The Sepsis Diagnostics Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sepsis Diagnostics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Diagnostics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Axis Shield
Becton Dickinson
bioMérieux
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific
Segment by Type
Point-of-Care Testing
Laboratory Testing
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Diagnostics Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostics Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Point-of-Care Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Sepsis Diagnostics Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostics Testing Market Perspective (2020-2031)
2.2 Global Sepsis Diagnostics Testing Growth Trends by Region
2.2.1 Global Sepsis Diagnostics Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sepsis Diagnostics Testing Historic Market Size by Region (2020-2025)
2.2.3 Sepsis Diagnostics Testing Forecasted Market Size by Region (2026-2031)
2.3 Sepsis Diagnostics Testing Market Dynamics
2.3.1 Sepsis Diagnostics Testing Industry Trends
2.3.2 Sepsis Diagnostics Testing Market Drivers
2.3.3 Sepsis Diagnostics Testing Market Challenges
2.3.4 Sepsis Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostics Testing Players by Revenue
3.1.1 Global Top Sepsis Diagnostics Testing Players by Revenue (2020-2025)
3.1.2 Global Sepsis Diagnostics Testing Revenue Market Share by Players (2020-2025)
3.2 Global Sepsis Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sepsis Diagnostics Testing Revenue
3.4 Global Sepsis Diagnostics Testing Market Concentration Ratio
3.4.1 Global Sepsis Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostics Testing Revenue in 2024
3.5 Global Key Players of Sepsis Diagnostics Testing Head office and Area Served
3.6 Global Key Players of Sepsis Diagnostics Testing, Product and Application
3.7 Global Key Players of Sepsis Diagnostics Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostics Testing Breakdown Data by Type
4.1 Global Sepsis Diagnostics Testing Historic Market Size by Type (2020-2025)
4.2 Global Sepsis Diagnostics Testing Forecasted Market Size by Type (2026-2031)
5 Sepsis Diagnostics Testing Breakdown Data by Application
5.1 Global Sepsis Diagnostics Testing Historic Market Size by Application (2020-2025)
5.2 Global Sepsis Diagnostics Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sepsis Diagnostics Testing Market Size (2020-2031)
6.2 North America Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sepsis Diagnostics Testing Market Size by Country (2020-2025)
6.4 North America Sepsis Diagnostics Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostics Testing Market Size (2020-2031)
7.2 Europe Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sepsis Diagnostics Testing Market Size by Country (2020-2025)
7.4 Europe Sepsis Diagnostics Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Testing Market Size (2020-2031)
8.2 Asia-Pacific Sepsis Diagnostics Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostics Testing Market Size (2020-2031)
9.2 Latin America Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sepsis Diagnostics Testing Market Size by Country (2020-2025)
9.4 Latin America Sepsis Diagnostics Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Testing Market Size (2020-2031)
10.2 Middle East & Africa Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sepsis Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Axis Shield
11.2.1 Axis Shield Company Details
11.2.2 Axis Shield Business Overview
11.2.3 Axis Shield Sepsis Diagnostics Testing Introduction
11.2.4 Axis Shield Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.2.5 Axis Shield Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Sepsis Diagnostics Testing Introduction
11.3.4 Becton Dickinson Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.3.5 Becton Dickinson Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Sepsis Diagnostics Testing Introduction
11.4.4 bioMérieux Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.4.5 bioMérieux Recent Development
11.5 Bruker
11.5.1 Bruker Company Details
11.5.2 Bruker Business Overview
11.5.3 Bruker Sepsis Diagnostics Testing Introduction
11.5.4 Bruker Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.5.5 Bruker Recent Development
11.6 Cytosorbents
11.6.1 Cytosorbents Company Details
11.6.2 Cytosorbents Business Overview
11.6.3 Cytosorbents Sepsis Diagnostics Testing Introduction
11.6.4 Cytosorbents Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.6.5 Cytosorbents Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Sepsis Diagnostics Testing Introduction
11.7.4 Danaher Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.7.5 Danaher Recent Development
11.8 Immunexpress
11.8.1 Immunexpress Company Details
11.8.2 Immunexpress Business Overview
11.8.3 Immunexpress Sepsis Diagnostics Testing Introduction
11.8.4 Immunexpress Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.8.5 Immunexpress Recent Development
11.9 Luminex
11.9.1 Luminex Company Details
11.9.2 Luminex Business Overview
11.9.3 Luminex Sepsis Diagnostics Testing Introduction
11.9.4 Luminex Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.9.5 Luminex Recent Development
11.10 Mitsubishi Chemical
11.10.1 Mitsubishi Chemical Company Details
11.10.2 Mitsubishi Chemical Business Overview
11.10.3 Mitsubishi Chemical Sepsis Diagnostics Testing Introduction
11.10.4 Mitsubishi Chemical Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.10.5 Mitsubishi Chemical Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Diagnostics Testing Introduction
11.11.4 Response Biomedical Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.11.5 Response Biomedical Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Sepsis Diagnostics Testing Introduction
11.12.4 Roche Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.12.5 Roche Recent Development
11.13 T2 Biosystems
11.13.1 T2 Biosystems Company Details
11.13.2 T2 Biosystems Business Overview
11.13.3 T2 Biosystems Sepsis Diagnostics Testing Introduction
11.13.4 T2 Biosystems Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.13.5 T2 Biosystems Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Sepsis Diagnostics Testing Introduction
11.14.4 Thermo Fisher Scientific Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostics Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Point-of-Care Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Sepsis Diagnostics Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostics Testing Market Perspective (2020-2031)
2.2 Global Sepsis Diagnostics Testing Growth Trends by Region
2.2.1 Global Sepsis Diagnostics Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sepsis Diagnostics Testing Historic Market Size by Region (2020-2025)
2.2.3 Sepsis Diagnostics Testing Forecasted Market Size by Region (2026-2031)
2.3 Sepsis Diagnostics Testing Market Dynamics
2.3.1 Sepsis Diagnostics Testing Industry Trends
2.3.2 Sepsis Diagnostics Testing Market Drivers
2.3.3 Sepsis Diagnostics Testing Market Challenges
2.3.4 Sepsis Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostics Testing Players by Revenue
3.1.1 Global Top Sepsis Diagnostics Testing Players by Revenue (2020-2025)
3.1.2 Global Sepsis Diagnostics Testing Revenue Market Share by Players (2020-2025)
3.2 Global Sepsis Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sepsis Diagnostics Testing Revenue
3.4 Global Sepsis Diagnostics Testing Market Concentration Ratio
3.4.1 Global Sepsis Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostics Testing Revenue in 2024
3.5 Global Key Players of Sepsis Diagnostics Testing Head office and Area Served
3.6 Global Key Players of Sepsis Diagnostics Testing, Product and Application
3.7 Global Key Players of Sepsis Diagnostics Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostics Testing Breakdown Data by Type
4.1 Global Sepsis Diagnostics Testing Historic Market Size by Type (2020-2025)
4.2 Global Sepsis Diagnostics Testing Forecasted Market Size by Type (2026-2031)
5 Sepsis Diagnostics Testing Breakdown Data by Application
5.1 Global Sepsis Diagnostics Testing Historic Market Size by Application (2020-2025)
5.2 Global Sepsis Diagnostics Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sepsis Diagnostics Testing Market Size (2020-2031)
6.2 North America Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sepsis Diagnostics Testing Market Size by Country (2020-2025)
6.4 North America Sepsis Diagnostics Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostics Testing Market Size (2020-2031)
7.2 Europe Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sepsis Diagnostics Testing Market Size by Country (2020-2025)
7.4 Europe Sepsis Diagnostics Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Testing Market Size (2020-2031)
8.2 Asia-Pacific Sepsis Diagnostics Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostics Testing Market Size (2020-2031)
9.2 Latin America Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sepsis Diagnostics Testing Market Size by Country (2020-2025)
9.4 Latin America Sepsis Diagnostics Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Testing Market Size (2020-2031)
10.2 Middle East & Africa Sepsis Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sepsis Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Axis Shield
11.2.1 Axis Shield Company Details
11.2.2 Axis Shield Business Overview
11.2.3 Axis Shield Sepsis Diagnostics Testing Introduction
11.2.4 Axis Shield Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.2.5 Axis Shield Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Sepsis Diagnostics Testing Introduction
11.3.4 Becton Dickinson Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.3.5 Becton Dickinson Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Sepsis Diagnostics Testing Introduction
11.4.4 bioMérieux Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.4.5 bioMérieux Recent Development
11.5 Bruker
11.5.1 Bruker Company Details
11.5.2 Bruker Business Overview
11.5.3 Bruker Sepsis Diagnostics Testing Introduction
11.5.4 Bruker Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.5.5 Bruker Recent Development
11.6 Cytosorbents
11.6.1 Cytosorbents Company Details
11.6.2 Cytosorbents Business Overview
11.6.3 Cytosorbents Sepsis Diagnostics Testing Introduction
11.6.4 Cytosorbents Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.6.5 Cytosorbents Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Sepsis Diagnostics Testing Introduction
11.7.4 Danaher Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.7.5 Danaher Recent Development
11.8 Immunexpress
11.8.1 Immunexpress Company Details
11.8.2 Immunexpress Business Overview
11.8.3 Immunexpress Sepsis Diagnostics Testing Introduction
11.8.4 Immunexpress Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.8.5 Immunexpress Recent Development
11.9 Luminex
11.9.1 Luminex Company Details
11.9.2 Luminex Business Overview
11.9.3 Luminex Sepsis Diagnostics Testing Introduction
11.9.4 Luminex Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.9.5 Luminex Recent Development
11.10 Mitsubishi Chemical
11.10.1 Mitsubishi Chemical Company Details
11.10.2 Mitsubishi Chemical Business Overview
11.10.3 Mitsubishi Chemical Sepsis Diagnostics Testing Introduction
11.10.4 Mitsubishi Chemical Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.10.5 Mitsubishi Chemical Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Diagnostics Testing Introduction
11.11.4 Response Biomedical Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.11.5 Response Biomedical Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Sepsis Diagnostics Testing Introduction
11.12.4 Roche Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.12.5 Roche Recent Development
11.13 T2 Biosystems
11.13.1 T2 Biosystems Company Details
11.13.2 T2 Biosystems Business Overview
11.13.3 T2 Biosystems Sepsis Diagnostics Testing Introduction
11.13.4 T2 Biosystems Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.13.5 T2 Biosystems Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Sepsis Diagnostics Testing Introduction
11.14.4 Thermo Fisher Scientific Revenue in Sepsis Diagnostics Testing Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sepsis Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Point-of-Care Testing
Table 3. Key Players of Laboratory Testing
Table 4. Global Sepsis Diagnostics Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sepsis Diagnostics Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sepsis Diagnostics Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sepsis Diagnostics Testing Market Share by Region (2020-2025)
Table 8. Global Sepsis Diagnostics Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sepsis Diagnostics Testing Market Share by Region (2026-2031)
Table 10. Sepsis Diagnostics Testing Market Trends
Table 11. Sepsis Diagnostics Testing Market Drivers
Table 12. Sepsis Diagnostics Testing Market Challenges
Table 13. Sepsis Diagnostics Testing Market Restraints
Table 14. Global Sepsis Diagnostics Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sepsis Diagnostics Testing Market Share by Players (2020-2025)
Table 16. Global Top Sepsis Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics Testing as of 2024)
Table 17. Ranking of Global Top Sepsis Diagnostics Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostics Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sepsis Diagnostics Testing, Headquarters and Area Served
Table 20. Global Key Players of Sepsis Diagnostics Testing, Product and Application
Table 21. Global Key Players of Sepsis Diagnostics Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sepsis Diagnostics Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sepsis Diagnostics Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Sepsis Diagnostics Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sepsis Diagnostics Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Sepsis Diagnostics Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sepsis Diagnostics Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Sepsis Diagnostics Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sepsis Diagnostics Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sepsis Diagnostics Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Company Details
Table 47. Abbott Business Overview
Table 48. Abbott Sepsis Diagnostics Testing Product
Table 49. Abbott Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Axis Shield Company Details
Table 52. Axis Shield Business Overview
Table 53. Axis Shield Sepsis Diagnostics Testing Product
Table 54. Axis Shield Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 55. Axis Shield Recent Development
Table 56. Becton Dickinson Company Details
Table 57. Becton Dickinson Business Overview
Table 58. Becton Dickinson Sepsis Diagnostics Testing Product
Table 59. Becton Dickinson Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 60. Becton Dickinson Recent Development
Table 61. bioMérieux Company Details
Table 62. bioMérieux Business Overview
Table 63. bioMérieux Sepsis Diagnostics Testing Product
Table 64. bioMérieux Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 65. bioMérieux Recent Development
Table 66. Bruker Company Details
Table 67. Bruker Business Overview
Table 68. Bruker Sepsis Diagnostics Testing Product
Table 69. Bruker Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 70. Bruker Recent Development
Table 71. Cytosorbents Company Details
Table 72. Cytosorbents Business Overview
Table 73. Cytosorbents Sepsis Diagnostics Testing Product
Table 74. Cytosorbents Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 75. Cytosorbents Recent Development
Table 76. Danaher Company Details
Table 77. Danaher Business Overview
Table 78. Danaher Sepsis Diagnostics Testing Product
Table 79. Danaher Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 80. Danaher Recent Development
Table 81. Immunexpress Company Details
Table 82. Immunexpress Business Overview
Table 83. Immunexpress Sepsis Diagnostics Testing Product
Table 84. Immunexpress Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 85. Immunexpress Recent Development
Table 86. Luminex Company Details
Table 87. Luminex Business Overview
Table 88. Luminex Sepsis Diagnostics Testing Product
Table 89. Luminex Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 90. Luminex Recent Development
Table 91. Mitsubishi Chemical Company Details
Table 92. Mitsubishi Chemical Business Overview
Table 93. Mitsubishi Chemical Sepsis Diagnostics Testing Product
Table 94. Mitsubishi Chemical Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 95. Mitsubishi Chemical Recent Development
Table 96. Response Biomedical Company Details
Table 97. Response Biomedical Business Overview
Table 98. Response Biomedical Sepsis Diagnostics Testing Product
Table 99. Response Biomedical Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 100. Response Biomedical Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Sepsis Diagnostics Testing Product
Table 104. Roche Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 105. Roche Recent Development
Table 106. T2 Biosystems Company Details
Table 107. T2 Biosystems Business Overview
Table 108. T2 Biosystems Sepsis Diagnostics Testing Product
Table 109. T2 Biosystems Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 110. T2 Biosystems Recent Development
Table 111. Thermo Fisher Scientific Company Details
Table 112. Thermo Fisher Scientific Business Overview
Table 113. Thermo Fisher Scientific Sepsis Diagnostics Testing Product
Table 114. Thermo Fisher Scientific Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Sepsis Diagnostics Testing Picture
Figure 2. Global Sepsis Diagnostics Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sepsis Diagnostics Testing Market Share by Type: 2024 VS 2031
Figure 4. Point-of-Care Testing Features
Figure 5. Laboratory Testing Features
Figure 6. Global Sepsis Diagnostics Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sepsis Diagnostics Testing Market Share by Application: 2024 VS 2031
Figure 8. General Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Sepsis Diagnostics Testing Report Years Considered
Figure 11. Global Sepsis Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Sepsis Diagnostics Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sepsis Diagnostics Testing Market Share by Region: 2024 VS 2031
Figure 14. Global Sepsis Diagnostics Testing Market Share by Players in 2024
Figure 15. Global Top Sepsis Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics Testing as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Sepsis Diagnostics Testing Revenue in 2024
Figure 17. North America Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 19. United States Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 23. Germany Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sepsis Diagnostics Testing Market Share by Region (2020-2031)
Figure 31. China Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 39. Mexico Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 43. Turkey Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 47. Axis Shield Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 48. Becton Dickinson Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 49. bioMérieux Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 50. Bruker Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 51. Cytosorbents Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 52. Danaher Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 53. Immunexpress Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 54. Luminex Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 55. Mitsubishi Chemical Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 56. Response Biomedical Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 57. Roche Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 58. T2 Biosystems Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Sepsis Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Point-of-Care Testing
Table 3. Key Players of Laboratory Testing
Table 4. Global Sepsis Diagnostics Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sepsis Diagnostics Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sepsis Diagnostics Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sepsis Diagnostics Testing Market Share by Region (2020-2025)
Table 8. Global Sepsis Diagnostics Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sepsis Diagnostics Testing Market Share by Region (2026-2031)
Table 10. Sepsis Diagnostics Testing Market Trends
Table 11. Sepsis Diagnostics Testing Market Drivers
Table 12. Sepsis Diagnostics Testing Market Challenges
Table 13. Sepsis Diagnostics Testing Market Restraints
Table 14. Global Sepsis Diagnostics Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sepsis Diagnostics Testing Market Share by Players (2020-2025)
Table 16. Global Top Sepsis Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics Testing as of 2024)
Table 17. Ranking of Global Top Sepsis Diagnostics Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostics Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sepsis Diagnostics Testing, Headquarters and Area Served
Table 20. Global Key Players of Sepsis Diagnostics Testing, Product and Application
Table 21. Global Key Players of Sepsis Diagnostics Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sepsis Diagnostics Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sepsis Diagnostics Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Sepsis Diagnostics Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sepsis Diagnostics Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Sepsis Diagnostics Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sepsis Diagnostics Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Sepsis Diagnostics Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sepsis Diagnostics Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sepsis Diagnostics Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sepsis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Company Details
Table 47. Abbott Business Overview
Table 48. Abbott Sepsis Diagnostics Testing Product
Table 49. Abbott Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Axis Shield Company Details
Table 52. Axis Shield Business Overview
Table 53. Axis Shield Sepsis Diagnostics Testing Product
Table 54. Axis Shield Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 55. Axis Shield Recent Development
Table 56. Becton Dickinson Company Details
Table 57. Becton Dickinson Business Overview
Table 58. Becton Dickinson Sepsis Diagnostics Testing Product
Table 59. Becton Dickinson Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 60. Becton Dickinson Recent Development
Table 61. bioMérieux Company Details
Table 62. bioMérieux Business Overview
Table 63. bioMérieux Sepsis Diagnostics Testing Product
Table 64. bioMérieux Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 65. bioMérieux Recent Development
Table 66. Bruker Company Details
Table 67. Bruker Business Overview
Table 68. Bruker Sepsis Diagnostics Testing Product
Table 69. Bruker Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 70. Bruker Recent Development
Table 71. Cytosorbents Company Details
Table 72. Cytosorbents Business Overview
Table 73. Cytosorbents Sepsis Diagnostics Testing Product
Table 74. Cytosorbents Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 75. Cytosorbents Recent Development
Table 76. Danaher Company Details
Table 77. Danaher Business Overview
Table 78. Danaher Sepsis Diagnostics Testing Product
Table 79. Danaher Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 80. Danaher Recent Development
Table 81. Immunexpress Company Details
Table 82. Immunexpress Business Overview
Table 83. Immunexpress Sepsis Diagnostics Testing Product
Table 84. Immunexpress Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 85. Immunexpress Recent Development
Table 86. Luminex Company Details
Table 87. Luminex Business Overview
Table 88. Luminex Sepsis Diagnostics Testing Product
Table 89. Luminex Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 90. Luminex Recent Development
Table 91. Mitsubishi Chemical Company Details
Table 92. Mitsubishi Chemical Business Overview
Table 93. Mitsubishi Chemical Sepsis Diagnostics Testing Product
Table 94. Mitsubishi Chemical Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 95. Mitsubishi Chemical Recent Development
Table 96. Response Biomedical Company Details
Table 97. Response Biomedical Business Overview
Table 98. Response Biomedical Sepsis Diagnostics Testing Product
Table 99. Response Biomedical Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 100. Response Biomedical Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Sepsis Diagnostics Testing Product
Table 104. Roche Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 105. Roche Recent Development
Table 106. T2 Biosystems Company Details
Table 107. T2 Biosystems Business Overview
Table 108. T2 Biosystems Sepsis Diagnostics Testing Product
Table 109. T2 Biosystems Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 110. T2 Biosystems Recent Development
Table 111. Thermo Fisher Scientific Company Details
Table 112. Thermo Fisher Scientific Business Overview
Table 113. Thermo Fisher Scientific Sepsis Diagnostics Testing Product
Table 114. Thermo Fisher Scientific Revenue in Sepsis Diagnostics Testing Business (2020-2025) & (US$ Million)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Sepsis Diagnostics Testing Picture
Figure 2. Global Sepsis Diagnostics Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sepsis Diagnostics Testing Market Share by Type: 2024 VS 2031
Figure 4. Point-of-Care Testing Features
Figure 5. Laboratory Testing Features
Figure 6. Global Sepsis Diagnostics Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sepsis Diagnostics Testing Market Share by Application: 2024 VS 2031
Figure 8. General Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Sepsis Diagnostics Testing Report Years Considered
Figure 11. Global Sepsis Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Sepsis Diagnostics Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sepsis Diagnostics Testing Market Share by Region: 2024 VS 2031
Figure 14. Global Sepsis Diagnostics Testing Market Share by Players in 2024
Figure 15. Global Top Sepsis Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics Testing as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Sepsis Diagnostics Testing Revenue in 2024
Figure 17. North America Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 19. United States Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 23. Germany Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sepsis Diagnostics Testing Market Share by Region (2020-2031)
Figure 31. China Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 39. Mexico Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sepsis Diagnostics Testing Market Share by Country (2020-2031)
Figure 43. Turkey Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Sepsis Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 47. Axis Shield Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 48. Becton Dickinson Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 49. bioMérieux Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 50. Bruker Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 51. Cytosorbents Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 52. Danaher Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 53. Immunexpress Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 54. Luminex Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 55. Mitsubishi Chemical Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 56. Response Biomedical Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 57. Roche Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 58. T2 Biosystems Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Sepsis Diagnostics Testing Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232